What Are My Treatment Options for Prostate Cancer?
Radiation, surgery or active surveillance—which one is right for you?
Category: Prostate Cancer
Should You Get Screened for Prostate Cancer?
The recommendations for prostate cancer screening have changed. Here’s what men need to know to protect themselves.
Low-risk prostate cancer best managed with active surveillance, acc...
A UNC Lineberger researcher was first-author of a report published in the Journal of Clinical Oncology that details guidelines for the active surveillance of men with low-risk prostate cancer. The guidelines, originally authored by Cancer Care Ontario, were reviewed and endorsed by the American Society of Clinical Oncology with some revisions.
New study shows on balance that prostate cancer prevention drug app...
The research team included Dr. Paul Godley of the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center.
IMRT may not be more effective than older radiation techniques afte...
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from UNC suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
African Americans experience longer delay between prostate cancer d...
The study is the first published population-based examination of racial disparities in prostate cancer treatment delay.
Intensity Modulated Radiation Therapy optimal for localized prostat...
A new study finds that a treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence.
UNC scientists collaborate to find first major genetic mutation ass...
After a 20-year quest, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.
Cancer, Collaboration, Genetics, Innovation, Prostate, Prostate Cancer